The conference will focus on recent advances and business opportunities in Clinical Research. About 400 delegates are expected to participate in the two-day event. The unique feature of this conference is that 10 International keynote speakers from US, Canada and UK along with highly acclaimed and eminent speakers of India from various Pharmaceutical Companies, CROs and Regulatory Bodies would be sharing their views and opinion in the conclave. FDA Regulations and Phase-I submission will be presented by FDA experts. There will be Scientific Sessions on the different streams of Clinical Research operations, Pharmacovigilance, CDM, Regulatory Affairs and submission with special emphasis on Phase-I Clinical Trials and Business Opportunities for allied players in the Clinical Research industry. The participants will have an opportunity to deliberate and discuss with the keynote speakers and a group of professional with common interests. The conference is designed for expert level professionals in the Pharmaceutical, Biotechnology, Medical Devices, Government, Support Services/Products, Academia, Logistics, Venture Capitalists, Bank, Insurance and related Healthcare Industries. The conference overarching objective is to position India as the preferred destination for the Science & Business of Clinical Research.